Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-23 Option Award | 2024-09-24 5:00 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Rubin Eyal Sr. VP and CFO | 99,010 | $0 | 669,010 (Indirect) | View |
| 2023-08-15 Option Award | 2023-08-17 4:30 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Rubin Eyal Sr. VP and CFO | 201,903 | $0 | 570,000 (Indirect) | View |
| 2022-09-07 Option Award | 2022-09-09 5:03 pm | N/A 2032-09-07 | Protalix BioTherapeutics Inc. | PLX | Rubin Eyal Sr. VP and CFO | 350,000 | $0 | 350,000 (Direct) | View |
| 2022-02-25 Option Award | 2022-02-28 5:02 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Rubin Eyal Sr. VP and CFO | 121,951 | $0 | 368,097 (Indirect) | View |
| 2020-08-11 Option Award(A) | 2020-08-14 5:01 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Rubin Eyal Sr. VP and CFO | 246,146 | $0 | 246,146 (Indirect) | View |
| 2020-08-11 Option Award | 2020-08-13 5:03 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Rubin Eyal Sr. VP and CFO | 246,146 | $0 | 246,146 (Indirect) | View |